How to express tumor markers in bronchoalveolar lavage

International Journal of Biological Markers

Volumn 19, Issue 1, 2004, Pages 67-71

  Gómez de Terreros Caro, Francisco Javier ^a   Alvarez Sala R ^a   Prados, M C ^a   Callol, L ^b   Gomez de Terreros Sanchez F J ^b   Villamor, J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Bronchoalveolar lavage; Lung cancer; Tumor markers

Indexed keywords

CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; PROTEIN; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BRONCHIOLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG ALVEOLUS; LUNG CANCER; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

EID: 1942518917     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/jbm.2008.3682     Document Type: Article

References (18)

1. Klech H, Hutter C. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990; 3: 937-74.
2. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-8.
3. Prados MC, Álvarez-Sala R, Blasco R, et al. The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage. Cancer 1994; 74: 1552-5.
4. Niklinski J, Chyczewska E, Furman M, Kowal E, Kozlowski M. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma. Neoplasma 1992; 39: 283-5.
5. Haslam PL, Baughman RP, eds. Report of European Respiratory Society (ERS) Task Force: guidelines for measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 1999; 9: 25-157.
6. Castella J, Ancoechea J, Llorente JL, et al. Lavado broncoalveolar. Arch Bronconeumol 1997; 33: 515-26.
7. Cristofori R, Aimo G, Mengozzi A, Revello F, Rapellino M. Tumor markers kinetic in malignant lung neoplasms. J Cardiovasc Surg (Torino) 1999; 40: 299-305.
8. Prados MC, Álvarez-Sala R, Terreros-Caro FJ, Gómez L, Gómez de Terreros FJ, Villamor J. The concentrations of five tumour markers in both BAL fractions in lung cancer patients in relation to cigarette smoking. Tumori 1999; 85: 454-7.
9. Prados C, Álvarez-Sala R, Gómez de Terreros J, et al. An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients. Jpn J Clin Oncol 2000; 30: 215-20.
10. Walters EH, Gardiner PV. Bronchoalveolar lavage as a research tool. Thorax 1991; 46: 613-8.
11. Rennard SI, Ghafouri MO, Thompson AB, et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis 1990; 141: 208-17.
12. Cremades MJ, Menéndez: R, Pastor A, Llopis R, Aznar J. Diagnostic value of cytokeratin fragment 19 (CYFRA 21-1) in bronchoalveolar lavage fluid in lung cancer. Respir Med 1998; 92: 766-71.
13. Von Eiff M, Koch O, Appelhans N, Roos N, van de Loo J. Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage. Pneumologie 1990; 44: 462-4.
14. Niklinski J, Chyczewski L, Chyczewska E, Laudanski J, Furman M. A correlative study of bronchial cytology, bronchoalveolar lavage (BAL) and serum tumor markers in the diagnosis of lung cancer. Folia Histochem Cytobiol 1993; 31: 211-3.
15. Trevisani L, Putinati S, Saltori S, Abbasciano V, Bagni B. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer. Chest 1996; 109: 104-8.
16. Alvarez-Sala R, Blasco R, Callol L, Laguna R, Alvarez-Sala JL, Gómez de Terreros FJ. Tumour markers in broncho-alveolar lavage. Acta Oncol 1989; 28: 290-1.
17. Pina TC, Zapata IT, Hernández FC, López JB, Paricio PP, Hernández PM. Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma. What environment lends the optimum diagnostic yield? Clin Chim Acta 2001; 305: 27-34.
18. Zaleska J, Pirozynski M, Kwiek S, Sakowicz A, Rowinska-Zakrzewska E. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer. Rocz Akad Med Bialymst 1997: 42; 179-89.